We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current IZTC market cap is 104.79M. The company's latest EPS is USD -0.3260 and P/E is -51.41.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 71k | 0 | 0 | 0 |
Operating Income | -1.58M | -1.01M | -1.33M | -1.61M |
Net Income | -1.1M | -1.01M | -1.36M | -1.66M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 71k |
Operating Income | -1.29M | -1.33M | -1.8M |
Net Income | -1.21M | -1.4M | -2.04M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 3.56M | 4.01M | 4.05M | 3.56M |
Total Liabilities | 3.94M | 5.26M | 6.32M | 7.16M |
Total Equity | -384k | -1.25M | -2.26M | -3.6M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2.35M | 2.69M | 3.56M |
Total Liabilities | 1.15M | 1.31M | 3.94M |
Total Equity | 1.2M | 1.37M | -384k |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||
Operating | -1.18M | 281k | -2.26M | -2.8M |
Investing | -311k | -142k | -180k | -149k |
Financing | 1M | -92k | 2.53M | 3.11M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.59M | -1.26M | -1.18M |
Investing | -312k | -87k | -311k |
Financing | 2.31M | 1.36M | 1M |
Market Cap | 104.79M |
Price to Earnings Ratio | -51.41 |
Price to Sales Ratio | 1.47k |
Price to Cash Ratio | 1.57k |
Price to Book Ratio | -272.89 |
Dividend Yield | - |
Shares Outstanding | 6.25M |
Average Volume (1 week) | 34.47k |
Average Volume (1 Month) | 40.8k |
52 Week Change | 50.99% |
52 Week High | 23.00 |
52 Week Low | 8.50 |
Spread (Intraday) | 10 (50%) |
Company Name | Invizyne Technologies Inc |
Address |
112 north curry street carson city, nevada 89703 |
Website | https://www.invizyne.com/ |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions